Gossamer Bio (NasdaqGS:GOSS) FY Conference November 11, 2025 10:00 AM ET Speaker2All right. I think we're ready to get started here. Thanks so much for joining us again for our second annual Guggenheim Healthcare Innovation Conference and on day two. Next up in this room, I'm Bob Mulvaney, one of the bio pharma analysts here at Daniel Crozier from the Guggenheim team, up on the stage with me as well. Next in this room, we have the Gossamer team. We have Brian Geraghty, the COO and CFO, and Bob Smith, the CE ...